RavenQuest and Bonify Announce One-Year Extension of Services Agreement
07 2월 2019 - 6:27AM
RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) –
(CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) announces that
RavenQuest will continue to provide management & consulting
services to Bonify Holdings Corporation (“Bonify”) under a one-year
contract extension. The one-year extension will begin when the
initial three-month contract expires at the end of March 2019,
taking the entire term of the services agreement through March
2020.
Bonify Chairman, Jeff Dyck, stated that “the
corrective action taken by RavenQuest has been very well received
by the regulators. Health Canada has acknowledged the
significant progress made inside our facility with respect to
Quality Management Systems. Our recent suspension was related
to past issues.”
“We’re extremely impressed with the
professionalism and expertise with which the RavenQuest team has
methodically handled our compliance challenges, and fully expect to
resume full cannabis sales activities in the near term with
RavenQuest steering our production and quality assurance,” Dyck
continued.
About RavenQuest BioMed Inc.
RavenQuest BioMed Inc. is a diversified publicly
traded cannabis company with divisions focused upon cannabis
production, management services & consulting and specialized
research & development. RavenQuest is a licensed producer
with facilities located in Markham, Ontario and Edmonton,
Alberta. RavenQuest maintains a research partnership with
Montreal’s McGill University focused upon cultivar (strain)
recognition, plant stabilization and yield maximization of the
cannabis plant. The Company focuses on partnerships with
Indigenous communities.
On Behalf of the Board of Directors
ofRAVENQUEST BIOMED INC.
“George Robinson” Chief Executive Officer
For further information, please contact:Mathieu
McDonald, Corporate Communications – 604-484-1230
Neither Canadian Stock Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the Canadian Stock Exchange) accepts responsibility for
the adequacy or accuracy of this press release, which has been
prepared by management.
Cautionary Note Regarding Forward-Looking
Statements
All statements in this press release, other than
statements of historical fact, are “forward-looking information”
with respect to the Company within the meaning of applicable
securities laws, including statements with respect to the
development of licensed cannabis production facilities, the
production and supply of cannabis to the BCLDB, .the launch of
consumer cannabis brands and the development of partnerships with
Indigenous communities. The Company provides forward-looking
statements for the purpose of conveying information about current
expectations and plans relating to the future and readers are
cautioned that such statements may not be appropriate for other
purposes. By its nature, this information is subject to inherent
risks and uncertainties that may be general or specific and which
give rise to the possibility that expectations, forecasts,
predictions, projections or conclusions will not prove to be
accurate, that assumptions may not be correct and that objectives,
strategic goals and priorities will not be achieved. These risks
and uncertainties include but are not limited to those identified
and reported in the Company’s public filings under the Company’s
SEDAR profile at www.sedar.com. Although the Company has attempted
to identify important factors that could cause actual actions,
events or results to differ materially from those described in
forward-looking information, there may be other factors that cause
actions, events or results not to be as anticipated, estimated or
intended. There can be no assurance that such information will
prove to be accurate as actual results and future events could
differ materially from those anticipated in such statements. The
Company disclaims any intention or obligation to update or revise
any forward-looking information, whether as a result of new
information, future events or otherwise unless required by law.
RavenQuest BioMed (CSE:RQB)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
RavenQuest BioMed (CSE:RQB)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024